Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Qiu

Showing results (771-780 of 775) with videos related to

Pageof 78
Sort By:
You have reached the last page of results.This site can display upto 775 results.
Platelets|July 3, 2020
Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of agePeng Zhao, Ming Hou, Yi Liu, et al.
Translational Pediatrics|December 10, 2025
Expert consensus on the off-label use of drugs for pediatric rare diseases in China (2025 edition)Xiaolan Mo, Houliang Deng, Jinlian Yang, et al.
Blood Advances|June 9, 2022
Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter studyShan Chong, Peng Zhao, Rui-Bin Huang, et al.
Chinese Medical Journal|August 31, 2012
Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in ChinaYue-Yun Lai, Xiao-Jun Huang, Zhen Cai, et al.
Science Bulletin|August 20, 2023
A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort studyZhuo-Yu An, Ye-Jun Wu, Yu Hou, et al.
Pageof 78

Showing results (771-780 of 775) with videos related to

Sort By:
Pageof 78
You have reached the last page of results.This site can display upto 775 results.
Platelets|July 3, 2020
Risk stratification and outcomes of intracranial hemorrhage in patients with immune thrombocytopenia under 60 years of agePeng Zhao, Ming Hou, Yi Liu, et al.
Translational Pediatrics|December 10, 2025
Expert consensus on the off-label use of drugs for pediatric rare diseases in China (2025 edition)Xiaolan Mo, Houliang Deng, Jinlian Yang, et al.
Blood Advances|June 9, 2022
Developing and validating a mortality prediction model for ICH in ITP: a nationwide representative multicenter studyShan Chong, Peng Zhao, Rui-Bin Huang, et al.
Chinese Medical Journal|August 31, 2012
Prognostic power of abnormal cytogenetics for multiple myeloma: a multicenter study in ChinaYue-Yun Lai, Xiao-Jun Huang, Zhen Cai, et al.
Science Bulletin|August 20, 2023
A life-threatening bleeding prediction model for immune thrombocytopenia based on personalized machine learning: a nationwide prospective cohort studyZhuo-Yu An, Ye-Jun Wu, Yu Hou, et al.
Pageof 78